GlassScriptPhysician profile
Cecilia Ann
NPI 1306212717
$2,127.28
in general payments reported to CMS, 2019-2025
18 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $489 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,802 · Education: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,802.44 |
| Education | $324.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $414.92 | 2024-2025 | |
| Abbvie INC. | $354.97 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $231.32 | 2024-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $196.95 | 2024-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $174.99 | 2024-2025 | |
| Janssen Biotech, INC. | $140.28 | 2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $92.53 | 2025 | |
| Ucb, INC. | $85.28 | 2025 | Bimzelx |
| Lilly USA, LLC | $83.16 | 2024-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $81.66 | 2025 | Adbry |
| Incyte Corporation | $57.79 | 2025 | Opzelura |
| Galderma Laboratories, L.P. | $46.90 | 2025 | Nemluvio |
| Amgen INC. | $43.49 | 2025 | Otezla |
| Organon LLC | $28.72 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.90 | 2024 | Spevigo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $26.07 | 2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $21.23 | 2024 | Sotyktu |
| Ani Pharmaceuticals, INC. | $19.12 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Ann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.